SCHEMBL31060976

SCHEMBL31060976

CC(CN1CCC(c2cc(-c3ccc(F)cc3)nn2-c2ncccn2)CC1)(C(=O)O)c1ccccc1.Oc1cc(Cc2cc(O)c(O)c(Br)c2Br)c(Br)c(Br)c1O

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 18/20 0.54
▸ CHRM2 P08172 2/20 0.34
▸ CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12185602 0.73 PRCP (0.70) PRCP
SCHEMBL14701380 0.72 PRCP (0.53) PRCPCHRM2CHRM1
SCHEMBL12185582 0.71 PRCP (1.00) PRCPCHRM2CHRM1
SCHEMBL14686540 0.70 PRCP (0.83) PRCP
SCHEMBL12185627 0.70 PRCP (1.00) PRCPCHRM2CHRM1
SCHEMBL14701354 0.70 PRCP (0.84) PRCP
SCHEMBL17826599 0.69 PRCP (0.80) PRCP
SCHEMBL14686430 0.68 PRCP (0.76) PRCP
SCHEMBL14686541 0.68 PRCP (1.00) PRCP
SCHEMBL14749330 0.66 PRCP (0.57) PRCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 — — EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 — — WO disclosed
Send feedback